The multiple cell types comprising blood have been thought to emerge from progenitors with progressively narrower lineage options. New data suggest that lineage fate may be determined earlier than thought and that myeloid progenitor populations are aggregates of individual lineage-restricted cells.
The bone marrow is a spectacular cell foundry generating between one and three hundred billion blood cells every day in humans. It dynamically shifts to make differing amounts of specific blood cell types based on need. How the system turns on and off and guides production of particular cells has been the substance of decades of work. The results are paradigmatic for broad biologic principles like the existence of multipotent, somatic stem cells and progenitors, growth factors, lineage-fate-determining transcription factors, and stem cell therapies. Much of hematopoiesis has been considered resolved science. However, work by Paul et al. and Perié et al. in this issue of Cell suggests that the canonical models need reworking and that some long forgotten controversies are alive again.
Seminal work by Till and McCulloch first demonstrated the existence of hematopoietic stem cells (HSCs) with the ability to regenerate all types of blood lineages (Becker et al., 1963) . Intermediate differentiation states were then identified owing to two advances-first, isolating cell populations according to their immunophenotype by flow cytometry and second, transplanting them to assess their differentiation potential (Chao et al., 2008) . This work led to the model that a HSC makes the binary choice to become myeloid or lymphoid, and if myeloid, it becomes a cellular intermediate capable of differentiating into all myeloid cell types (erythrocytes, platelets, monocytes, dendritic cells, and granulocytes): a common myeloid progenitor (CMP) (Akashi et al., 2000) . This cell, conceived to be in a state of transcriptional equipoise, could be directed to any of several fates ( Figure 1A) .
Using single-cell transcriptional profiling and functional assays, Paul and colleagues found that myeloid progenitors commit very early to differentiation toward distinct blood lineages. Analyzing RNAsequencing data of 2,730 single lineage-negative, Sca-1 À , c-Kit + myeloid progenitors, they found that individual cells cluster into lineage-specific differentiation programs (Paul et al., 2015) . Contrary to previous thought, very few progenitors express multiple transcription factors regulating different fates.
Perié and colleagues took a different approach (Perié et al., 2015) . They sorted bulk populations of hematopoietic progenitors, labeled them ex vivo with a library of lentiviral barcodes, and transplanted them into mice to track their fate in vivo. They found that very few CMPs generated both erythroid and myeloid cells. Interestingly, by applying the same experimental design to immunophenotypically defined HSCs and multipotent progenitors (MPPs), they found that HSCs were capable of multi-lineage reconstitution (erythroid, myeloid, and dendritic cells in their assay), while MPPs showed an intermediate phenotype: some, but not all, committed to a single lineage. These two studies used different experimental approaches but reached a similar conclusion: ''common'' myeloid progenitors, which were previously thought to be a uniform population of cells with multi-lineage differentiation potential, are a heterogeneous mixture of progenitors for the most part already committed to a specific lineage, transcriptionally and functionally. This conclusion is consistent with a recent report by Notta et al. (2015) , wherein they used improved techniques for cell sorting, single-cell culture, and transplantation to demonstrate that the majority of myeloid progenitors from adult humans are committed to a single lineage.
Historically, hematopoietic progenitor cells have been studied as bulk-sorted populations, rendering it difficult to discern functional heterogeneity among the members of the group. However, a number of studies have now focused on providing greater resolution to the populations previously regarded as uniform. These include multiple complementary studies that challenge the hypothesis that granulocytic, monocytic, erythroid, and megakaryocytic cells arise from a uniform pool of progenitors. First, several groups have demonstrated that ''classical'' HSCs with multilineage potential reconstitute with a bias toward specific lineages. For example, Sanjuan-Pla et al. (2013) used a fluorescent reporter system to identify fractions of HSCs with different platelet-reconstitution potentials, and Dykstra et al. (2007) transplanted a large number of single flowsorted HSCs in individual recipients to demonstrate functional heterogeneity at the level of lymphoid and myeloid reconstitution. Second, several groups have identified, in mice, lineage-restricted progenitors with long-term self-renewal capacity. Yamamoto et al. (2013) used a strategy of single-cell sorting and transplantation to show that two kinds of cells can give rise to long-term reconstitution: ''classical'' HSCs with multi-lineage potential and lineage-restricted myeloid progenitors with long-term self-renewal capacity. Sun et al. (2014) generated a mouse model of endogenous genetic labeling that enables clonal tracking of hematopoietic output. They observed that the majority of the myeloid output is driven by a transient, clonal succession of lineage-restricted cells. Overall, this recent body of work suggests an alternate structure of the hematopoietic system, where a pool of progenitors is committed to lineages upstream of the CMP stage ( Figure 1B) .
Collectively, this work makes clear that primitive blood cells are not blank slates waiting for instruction on what to become. They are largely pre-programmed with strong biases to make specific lineage types, and making one lineage type is not inconsistent with having stem-cell-like self-renewing capability. This ''hard-wiring'' of cell lineage fate may extend up the hematopoietic cascade to the stem cell itself, implying that our stem/progenitor cell pools may not be a collection of equipotent cells but, rather, a complex mix of cells with varying capability: we have known them previously by the average of their activity. Now we might be able to pick subsets of interest to achieve particular outcomes of clinical importance.
The hard-wiring of lineage fates may also explain a perplexing aspect of hematopoiesis. Why, if stem cells are self-renewing and multipotent, don't we get multi-lineage leukemias? It would be expected that self-renewing cells would be the ones most likely to accumulate genetic injury that drives oncogenesis. Yet, the vast majority of acute leukemias are lineage restricted, implying a cell of origin well past the multipotent stages associated with self-renewal. It now appears that lineage-restricted cells may have self-renewing capability. Thus, they may not need to ''re-acquire'' the ability to self-renew that is needed to become a disease-producing malignant clone. cell production in the system be maintained? When the niche concept was first proposed in 1978, growth factors were largely unknown and controversy about the existence of a niche was heated. The prevailing wisdom was that stem cells did their thing and didn't need instruction. It is now well accepted that niches provide essential guidance to stem cell functions. However, the studies noted above raise questions about whether lineage fate is among those niche-governed events. Perhaps the niche is a system for integrating signals to turn on or off particular cells, but not for driving their lineage fate selection. Much more work is to be done to understand this almostunderstood system.
